Unknown sector · Pharmaceuticals, Biotechnology & Life Sciences
· website
$0.03
52wk 0.03 – 0.05
Overall
46.2
Value
67.7
Growth
0.0
Health
100.0
Quality
0.0
Momentum
53.6
Dividend
—
Price
About Patrys Limited
Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and inflammatory diseases. The Company's portfolio includes an injectable quetiapine program for the treatment of delirium and its versatile deoxymab antibody platform, including PAT-DX1 and PAT-DX3, which is being developed for applications in inflammatory and autoimmune diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and cancers and/or metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.
Price analytics
Returns
1 day
-3.0%
1 week
3.2%
1 month
6.7%
3 months
-17.9%
6 months
14.3%
1 year
—
3 years
—
Risk
Volatility (1y ann.)
86.8%
Beta vs ASX 200
1.15
Sharpe (1y)
0.26
VaR 95% (1-day)
-7.5%
Max drawdown (1y)
-44.4%
Off 1-year high
-34.7%
Technicals
RSI(14)
43
vs 50DMA
-2.9%
vs 200DMA
-4.5%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value67.7
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
82
Price / Sales
0
Growth0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health100.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
100
Debt / Equity
—
Quality (Profitability & Cash Flow)0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum53.6
6-month return vs ASX 200
100
Price vs 200-day average
35
Price vs 50-day average
35
Position in 52-week range
26
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).